Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of Humira (adalimumab) in severe psoriasis
2006-004260-31Phase 3Completed
- Sponsor
- University Hospitals of Leicester NHS Trust
- Start
- Jan 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of adalimumab in psoriasis, sponsored by University Hospitals of Leicester NHS Trust. Primary endpoint: Absolute percentage area of involvement <5%. Started Jan 2007; status: completed.
02
Drugs
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2006-004260-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004260-31.